http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2008114487-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 2008-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-WO2008114487-A1
titleOfInvention A therapeutic agent for autoimmune skin diseases comprising a polypeptide as an active ingredient
abstract An object of the present invention is to provide a novel medicine for autoimmune skin diseases, particularly bullous pemphigoid. A therapeutic agent for autoimmune skin diseases, comprising as an active ingredient a polypeptide that specifically binds to human type XVII collagen and inhibits the binding between human type XVII collagen and autoantibodies thereto. The therapeutic agent for autoimmune skin disease of the present invention uses a polypeptide having a high specificity for the causative factor of the disease, and there is no worry about side effects as compared with conventional therapeutic agents such as steroids. Therefore, it is possible to provide a fundamental treatment for the disease.
priorityDate 2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID324678
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1308
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450235101
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13518
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86598188
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396503
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID557257
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID316313
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID568794
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07631
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12821
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID294027

Total number of triples: 33.